Citropten is a coumarin that is mainly found in fruits of Rutaceae trees, but its anti-inflammatory activities in colitis is still unknown. In this study, we investigated its attenuating effect of citropten isolated from Citrus aurantifolia extract on DSS-induced colitis through the modulation of the activity of T cells and intestinal epithelial cells. We found that pre-treatment with citropten downregulates the activity of T cells and intestinal epithelial cells without a negative effect on the viability of Jurkat and HT-29 cells. The results from the Western blot analysis revealed that pre-treatment with citropten reduces the NFκB and MAPK signaling pathway in activated T cells and intestinal epithelial cells. We elucidated that the oral administration of citropten alleviates the colonic inflammation and activity of effector T cells in DSS-induced colitis by measuring changes in body weight, histological scoring from H&E-stained sections, mRNA levels of pro-inflammatory cytokines and the phosphorylation level of the MAPK signaling pathway.
Atopic dermatitis (AD) is a highly recurrent chronic inflammatory skin disease, characterized by severe itching, immune imbalance, and skin barrier dysfunction. Damage to the skin barrier function is known to be the main cause of Th1/Th2 immune imbalance, due to the Th2-mediated immune response, and pro-inflammatory cytokines, including IL-4, IL-5, IL-13 and IL-31 and it plays an important role in further eliciting the environment of AD through stimulation. Currently, the most widely used drugs for the treatment of AD are corticosteroids, antihistamines and immunosuppressants (used by more than 60% of patients), which are reported to exhibit various side effects when taken for a long time. Therefore, interest in the physiological activity of safer plant-derived natural extracts is increasing. Callicarpa dichotoma is traditionally used in oriental medicine for bruises, habitual pain, gastric and postpartum hemorrhage. Recent studies have reported that it exhibits antioxidant anti-inflammatory and anti-hepatotoxic activity, but the role and activity of C. dichotoma in AD have not yet been studied. Therefore, in this study, the new physiological activity of C. dichotoma in the AD environment was investigated, suggesting its potential as a natural therapeutic agent.
24 July 2025 in International Journal of Biological Sciences
Sesamin, a natural lignan derived from Sesamum indicum, has been reported to possess anti-inflammatory and pro-apoptotic properties. However, its effect on T cell-mediated diseases and the underlying molecular mechanisms remain unclear. In this study, we demonstrate that sesamin selectively induces apoptosis in activated T cells through direct interaction with MCL-1, a critical anti-apoptotic protein of the Bcl-2 family. Sesamin suppressed IL-2 expression, CD69 upregulation, and proliferation in activated human and murine T cells. Molecular docking predicted strong binding of sesamin to the BH3-binding groove of MCL-1, which was validated by pull-down and co-immunoprecipitation assays. Sesamin inhibited MCL-1 phosphorylation at Ser64 and disrupted its heterodimerization with Bak, promoting caspase-3/8 cleavage and apoptotic death selectively in activated, but not resting, T cells. In a murine model of atopic dermatitis, oral administration of sesamin ameliorated pathological skin symptoms, reduced Th2/Th17 cytokine expression, serum IgE, mast cell infiltration, and lymph node hypertrophy. These effects correlated with suppressed MCL-1 activity and enhanced apoptosis in inflamed tissue. Our findings suggest that sesamin modulates immune responses via a novel MCL-1-dependent mechanism and represents a promising dietary-derived therapeutic strategy for T cell-driven chronic inflammatory diseases.
31 July 2025 in World Journal of Traditional Chinese Medicine
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease involving T cell activation and elevated IgE levels. Betula platyphylla (BP) and Dictamnus dasycarpus (DD) are traditional medicinal herbs with known anti-inflammatory properties. However, their combined effect on T cell regulation in AD has not been fully explored. Aims and Objectives: This study aimed to evaluate the synergistic immunomodulatory effects of a BP and DD formulation (BPDD) on T cell activity and its therapeutic potential in treating AD. Materials and Methods: Jurkat T cells were pretreated with BPDD and stimulated using CD3/CD28 antibodies or SEE-pulsed Raji B cells. IL-2 production and CD69 expression were measured. Western blotting assessed NF-κB (p65) translocation and mitogen-activated protein kinase (MAPK) pathway activation. An AD mouse model was induced using HDM and DNCB. BPDD was orally administered (50–200 mg/kg), and outcomes were evaluated by measuring ear thickness, histopathology, mast cell infiltration, serum IgE, and cytokine expression. Results: BPDD showed no cytotoxicity and significantly reduced IL-2 and CD69 expression in T cells. It inhibited p65 nuclear translocation and phosphorylation of JNK and p38 MAPK. In vivo , BPDD alleviated AD symptoms by reducing skin inflammation, IgE levels, and inflammatory cytokines. It also normalized lymph node size, indicating systemic immune regulation. Conclusions: BPDD effectively suppresses T cell-mediated inflammation via NF-κB and MAPK pathways. It shows promise as a safe and effective herbal therapeutic for managing atopic dermatitis.